Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2344170546;70547;70548 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
N2AB2180065623;65624;65625 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
N2A2087362842;62843;62844 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
N2B1437643351;43352;43353 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
Novex-11450143726;43727;43728 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
Novex-21456843927;43928;43929 chr2:178575811;178575810;178575809chr2:179440538;179440537;179440536
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAC
  • RefSeq wild type template codon: TTG
  • Domain: Fn3-58
  • Domain position: 7
  • Structural Position: 7
  • Q(SASA): 0.5199
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/K rs751179969 0.266 0.117 N 0.287 0.12 0.126345400529 gnomAD-2.1.1 4.02E-06 None None None None I None 6.46E-05 0 None 0 0 None 0 None 0 0 0
N/K rs751179969 0.266 0.117 N 0.287 0.12 0.126345400529 gnomAD-4.0.0 6.84472E-07 None None None None I None 0 0 None 0 0 None 0 0 8.99824E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.3028 likely_benign 0.3673 ambiguous -0.371 Destabilizing 0.966 D 0.583 neutral None None None None I
N/C 0.3177 likely_benign 0.3915 ambiguous 0.268 Stabilizing 1.0 D 0.765 deleterious None None None None I
N/D 0.2044 likely_benign 0.2398 benign 0.119 Stabilizing 0.977 D 0.484 neutral N 0.515425428 None None I
N/E 0.5174 ambiguous 0.6121 pathogenic 0.122 Stabilizing 0.966 D 0.505 neutral None None None None I
N/F 0.6236 likely_pathogenic 0.7026 pathogenic -0.524 Destabilizing 1.0 D 0.746 deleterious None None None None I
N/G 0.275 likely_benign 0.308 benign -0.602 Destabilizing 0.983 D 0.431 neutral None None None None I
N/H 0.1086 likely_benign 0.1273 benign -0.52 Destabilizing 0.997 D 0.618 neutral N 0.487215904 None None I
N/I 0.5426 ambiguous 0.6461 pathogenic 0.162 Stabilizing 0.997 D 0.767 deleterious N 0.511067377 None None I
N/K 0.3763 ambiguous 0.4809 ambiguous 0.001 Stabilizing 0.117 N 0.287 neutral N 0.481099837 None None I
N/L 0.4105 ambiguous 0.4858 ambiguous 0.162 Stabilizing 0.995 D 0.679 prob.neutral None None None None I
N/M 0.5151 ambiguous 0.5975 pathogenic 0.405 Stabilizing 1.0 D 0.718 prob.delet. None None None None I
N/P 0.8574 likely_pathogenic 0.9033 pathogenic 0.013 Stabilizing 0.998 D 0.733 prob.delet. None None None None I
N/Q 0.3507 ambiguous 0.4187 ambiguous -0.451 Destabilizing 0.995 D 0.641 neutral None None None None I
N/R 0.3834 ambiguous 0.4781 ambiguous 0.026 Stabilizing 0.99 D 0.588 neutral None None None None I
N/S 0.1119 likely_benign 0.1238 benign -0.318 Destabilizing 0.977 D 0.409 neutral N 0.508366169 None None I
N/T 0.2671 likely_benign 0.3276 benign -0.154 Destabilizing 0.977 D 0.535 neutral N 0.492963122 None None I
N/V 0.5011 ambiguous 0.5997 pathogenic 0.013 Stabilizing 0.995 D 0.752 deleterious None None None None I
N/W 0.8557 likely_pathogenic 0.9057 pathogenic -0.451 Destabilizing 1.0 D 0.765 deleterious None None None None I
N/Y 0.2481 likely_benign 0.3108 benign -0.207 Destabilizing 0.999 D 0.74 deleterious D 0.538325891 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.